Second Opinion & Treatment Review
Dana-Farber Cancer Institute
Independent second opinions and structured review of treatment recommendations.
PROFILE OVERVIEW
Second Opinion & Treatment Review
Independent second opinions and structured review of treatment recommendations.
Profile notes in the final report
Neue oder veränderte Diagnose beziehungsweise Therapieplan als Anlässe genannt.Original German excerpt from the IAMBI 2026 final report.
IAMBI BENCHMARK ATLAS · 2026
The result in context.
M4 · Second Opinion & Treatment Review
ASSESSMENT
3.5 / 100Assessment in the IAMBI Benchmark 2026.
EVIDENCE COVERAGE
10.4 %Extent of the recorded evidence base.
Study assignment & result source
- Profile
- O169 · Dana-Farber Cancer Institute
- Study reference market
- United States
- Result
- 3.5 / 100 · Segment rank 20
- Source
- IAMBI Benchmark 2026 · Final report · Table 5, row 21
The reference market identifies the assignment within this study. An organization’s international presence is described in its portrait.
Data basis · IAMBI Benchmark 2026
IAMBI Benchmark 2026 scores represent calculated criteria values. The Atlas presents the transmitted results and their associated evidence coverage consistently across profiles, rankings, charts and data exports. The methodology explains criteria, evidence and peer groups.
Methodology & sources